Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation

Background: Allergic asthma is a long-term disorder of the airways resulting from overexpression of immunoglobulin E (IgE) in response to environmental allergens. Patients with poorly controlled asthma are at high risk of exacerbations requiring additional treatment, including hospitalisations. Seve...

Full description

Bibliographic Details
Main Authors: G Norman, R Faria, F Paton, A Llewellyn, D Fox, S Palmer, I Clifton, J Paton, N Woolacott, C McKenna
Format: Article
Language:English
Published: NIHR Journals Library 2013-11-01
Series:Health Technology Assessment
Subjects:
adults
asthma
children
omalizumab
systematic review
Online Access:https://doi.org/10.3310/hta17520

Internet

https://doi.org/10.3310/hta17520

Similar Items